I agree that this site is using cookies. You can find further informations here.
X
Labriola, Matthew
67  results:
Search for persons X
?
1

Patient engagement in designing and publishing research in ..:

Sutton, Linda ; Labriola, Matthew ; Bognanno, Thomas...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
2

Clinical implications of AR alterations in advanced prostat..:

Zengin, Zeynep B. ; Henderson, Nicholas C. ; Park, Joseph J....
Prostate Cancer and Prostatic Diseases.  , 2024
Link: https://doi.org/10.1038/..
 
?
3

Considerations for Designing and Implementing a Multi-insti..:

King, Steven ; Wu, Emma Y. ; Lin, Christine..
Journal of Cancer Education.  38 (2023)  5 - p. 1636-1640 , 2023
Link: https://doi.org/10.1007/..
 
?
4

PROMISE: a real-world clinical-genomic database to address ..:

Koshkin, Vadim S. ; Patel, Vaibhav G. ; Ali, Alicia...
Prostate Cancer and Prostatic Diseases.  25 (2021)  3 - p. 388-396 , 2021
Link: https://doi.org/10.1038/..
 
?
5

Proliferative potential and response to nivolumab in clear ..:

Zhang, Tian ; Pabla, Sarabjot ; Lenzo, Felicia L....
OncoImmunology.  9 (2020)  1 - p. , 2020
Link: https://doi.org/10.1080/..
 
?
6

Pazopanib in the Treatment of Bilateral Multifocal Renal On..:

Labriola, Matthew ; Foo, Wen-Chi ; George, Daniel J..
Clinical Genitourinary Cancer.  16 (2018)  3 - p. e509-e512 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Fabrication of bionanocomposites comprising flat nanocrysta..:

Bayer, Ilker S. ; Ghosh, Anindya ; Labriola, Matthew...
RSC Advances.  3 (2013)  43 - p. 20315 , 2013
Link: https://doi.org/10.1039/..
 
?
8

Setting a new standard for long‐term survival in metastatic..:

Labriola, Matthew K. ; George, Daniel J.
Cancer.  128 (2022)  11 - p. 2058-2060 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Remission of progressive metastatic castration-resistant pr..:

Seale, Katelyn Nazaneen ; Labriola, Matthew K ; Jiang, Xiaoyin "Sara".
BMJ Case Reports.  15 (2022)  10 - p. e251036 , 2022
Link: https://doi.org/10.1136/..
 
?
10

Evaluation of tumor microenvironment and biomarkers of immu..:

Brown, Landon C ; Zhu, Jason ; Desai, Kunal...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005249 , 2022
Link: https://doi.org/10.1136/..
 
?
11

LRP1Bmutations are associated with favorable outcomes to im..:

Brown, Landon C ; Tucker, Matthew D ; Sedhom, Ramy...
Journal for ImmunoTherapy of Cancer.  9 (2021)  3 - p. e001792 , 2021
Link: https://doi.org/10.1136/..
 
?
12

PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma ..:

Brown, Landon C. ; Zhu, Jason ; Labriola, Matthew K....
Clinical Genitourinary Cancer.  18 (2020)  6 - p. 509-513 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Management of men with metastatic castration-resistant pros..:

Labriola, Matthew K. ; Atiq, Saad ; Hirshman, Nathan.
Prostate Cancer and Prostatic Diseases.  24 (2020)  2 - p. 301-309 , 2020
Link: https://doi.org/10.1038/..
 
?
14

Characterization of tumor mutation burden, PD-L1 and DNA re..:

Labriola, Matthew Kyle ; Zhu, Jason ; Gupta, Rajan...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000319 , 2020
Link: https://doi.org/10.1136/..
 
?
15

Immunotherapy Is Changing First-Line Treatment of Metastati..:

Labriola, Matthew K. ; Batich, Kristen A. ; Zhu, Jason...
Clinical Genitourinary Cancer.  17 (2019)  3 - p. e513-e521 , 2019
Link: https://doi.org/10.1016/..
 
1-15